Top Markets
Coin of the day
Zenas BioPharma, Inc. Zenas BioPharma, Inc.

Zenas BioPharma, Inc.

ZBIO
Rang în acțiuni #6354
Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm,... Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm, concentrating on the creation and market introduction of innovative, immunology-based treatments. The company's primary investigational therapy is obexelimab, a distinctive bifunctional monoclonal antibody intended to address multiple diseases such as immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. Its developmental portfolio also features ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Established in 2019, the entity was formerly recognized as Zenas BioPharma (Cayman) Limited before adopting its current name, Zenas BioPharma, Inc., in August 2023. Its headquarters are located in Waltham, Massachusetts.
Preț acțiune
$33.00
Capitalizare de piață
$2.08B
Schimbare (1 zi)
-0.12%
Schimbare (1 an)
97.49%
Țară
US
Tranzacționează Zenas BioPharma, Inc. (ZBIO)

Categorie

Istoric al prețului acțiunii pentru Zenas BioPharma, Inc. (ZBIO)
Cel mai mare preț de închidere: $31.75 pe 2026-08-01

Cel mai mic preț de închidere: $17.96 pe 2024-09-01
Istoric al prețului acțiunii pentru Zenas BioPharma, Inc. din 2024 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -33.58%
2025 294.97%
2024 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$548.36 40.94%
US
$1.06K 49.46%
NL
$122.63 -12.65%
AU
$140.81 461.00%
US
$765.25 7.19%
CH